P
PROCEPT BioRobotics
Surgical robotics company enabling better patient care by developing transformative solutions in urology
About PROCEPT BioRobotics
PROCEPT BioRobotics is a pioneering medical technology company specializing in the development of advanced robotic solutions for the treatment of benign prostatic hyperplasia (BPH). BPH is a common condition in older men that causes enlargement of the prostate gland, leading to uncomfortable urinary symptoms. The company's flagship product, the AquaBeam Robotic System, performs Aquablation therapy, which is a minimally invasive surgical procedure that uses a combination of real-time imaging, robotics, and waterjet technology to remove prostate tissue with high precision.
Read full description
PROCEPT BioRobotics primarily serves urologists and healthcare institutions that treat patients suffering from BPH. The company operates in the medical device market, focusing on innovative surgical solutions that improve patient outcomes and streamline surgical procedures.
The business model of PROCEPT BioRobotics revolves around the sale and distribution of the AquaBeam Robotic System and associated consumables. The company generates revenue through the initial sale of the robotic system to hospitals and clinics, as well as recurring revenue from the sale of disposable components required for each procedure. Additionally, PROCEPT offers training and support services to ensure that healthcare providers can effectively utilize their technology.
PROCEPT BioRobotics has established itself as a leader in the field by providing a solution that offers predictable and reproducible outcomes, reducing the risk of complications and improving the quality of life for patients. The company's technology has been recognized and included in clinical practice guidelines, further solidifying its position in the market.
At a glance
- Founded
- 2009
- Headquarters
- Redwood City, United States
- Listing
- IPO 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later10 investors entered at this stage
Novo Seeds
Novo Holdings
Viking Global Investors
Perceptive Advisors
Armentum Partners
Fidelity Investments
T. Rowe Price- CPCPMG
Duquesne Family Office
CIBC Innovation Banking
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
33 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about PROCEPT BioRobotics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PROCEPT BioRobotics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.